March 28, 2022 -- Virtuoso Therapeutics will present two posters at the American Association for Cancer Research (AACR) 2022 annual meeting. The posters will highlight the company's preclinical data from its leading bispecific antibody programs, the company said.
The poster, "Multiple modes of action of the CD38 x ICAM-1 bispecific antibody" (5385), will be presented on Friday, April 8, 12-1 p.m. CT. The other poster, "CD47 x ICAM-1 bispecific antibody represents a novel approach for treating ICAM-1 overexpressing tumors" (3430) will be presented on Tuesday, April 12, 1:30-5 p.m. CT.
Copyright © 2022 scienceboard.net
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Conferences
Connect
